Picture of Valbiotis SA logo

ALVAL — Valbiotis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Valbiotis SA Valbiotis Announces Approval To Launch Two Phase Ii/Iii Insight And Insight 2 Clinical Studies

Feb 17 (Reuters) - Valbiotis SA  ALVAL.PA :
    * VALBIOTIS ANNOUNCES APPROVAL TO LAUNCH TWO PHASE II/III
INSIGHT
AND INSIGHT 2 CLINICAL STUDIES
    * THESE AUTHORIZATIONS ENABLE SIMULTANEOUS LAUNCH OF
RECRUITMENT
FOR THESE INTERNATIONAL STUDIES, WHICH SHOULD BE COMPLETED IN
FIRST HALF OF 2023

Source text for Eikon:  ID:nBwDdZ5ya 
Further company coverage:  ALVAL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Valbiotis SA

See all news